EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Thalidomide Attenuates Epileptogenesis and Seizures by Decreasing Brain Inflammation in Lithium Pilocarpine Rat Model

Irán M Cumbres-Vargas, Sergio R Zamudio, Luz A Pichardo-Macías, Eduardo Ramírez-San Juan

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24076488 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Irán M Cumbres-Vargas und 3 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Fisiología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City 07738, Mexico. Hauptthemen laut MEDLINE: Epilepsy, Temporal Lobe, Status Epilepticus, Encephalitis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Secretaría de Investigación y Posgrado—Instituto Politécnico Nacional.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thalidomide (TAL) has shown potential therapeutic effects in neurological diseases like epilepsy. Both clinical and preclinical studies show that TAL may act as an antiepileptic drug and as a possible treatment against disease development. However, the evidence for these effects is limited. Therefore, the antiepileptogenic and anti-inflammatory effects of TAL were evaluated herein. Sprague Dawley male rats were randomly allocated to one of five groups (n = 18 per group): control (C); status epilepticus (SE); SE-TAL (25 mg/kg); SE-TAL (50 mg/kg); and SE-topiramate (TOP; 60mg/kg). The lithium-pilocarpine model was used, and one day after SE induction the rats received pharmacological treatment for one week. The brain was obtained, and the hippocampus was micro-dissected 8, 18, and 28 days after SE. TNF-α, IL-6, and IL-1β concentrations were quantified. TOP and TAL (50 mg/kg) increased the latency to the first of many spontaneous recurrent seizures (SRS) and decreased SRS frequency, as well as decreasing TNF-α and IL-1β concentrations in the hippocampus. In conclusion, the results showed that both TAL (50 mg/kg) and TOP have anti-ictogenic and antiepileptogenic effects, possibly by decreasing neuroinflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epilepsy, Temporal LobeStatus EpilepticusEncephalitisRatsMaleAnimalsPilocarpineLithiumThalidomideRats, Sprague-DawleyTumor Necrosis Factor-alphaSeizuresHippocampusDisease Models, Animal

Stichwörter der Autor:innen

anti-ictogenicantiepileptogenicneuroinflammationtemporal lobe epilepsythalidomide

Substanzen

PilocarpineLithiumThalidomideTumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Departamento de Fisiología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City 07738, Mexico.

Förderung

  • Secretaría de Investigación y Posgrado—Instituto Politécnico Nacional

Zitieren

APA

Cumbres-Vargas, I. M., Zamudio, S. R., Pichardo-Macías, L. A., & Ramírez-San Juan, E. (2023). Thalidomide Attenuates Epileptogenesis and Seizures by Decreasing Brain Inflammation in Lithium Pilocarpine Rat Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24076488

Vancouver

Cumbres-Vargas IM, Zamudio SR, Pichardo-Macías LA, Ramírez-San Juan E. Thalidomide Attenuates Epileptogenesis and Seizures by Decreasing Brain Inflammation in Lithium Pilocarpine Rat Model. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24076488

BibTeX
@article{CumbresVargas2023,
  author = {Cumbres-Vargas, Irán M and Zamudio, Sergio R and Pichardo-Macías, Luz A and Ramírez-San Juan, Eduardo},
  title = {Thalidomide Attenuates Epileptogenesis and Seizures by Decreasing Brain Inflammation in Lithium Pilocarpine Rat Model},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24076488}
}
Kostenlos starten →